Nested high-resolution melting curve analysis: A highly sensitive, reliable, and simple method for detection of Jak2 exon 12 mutations-clinical relevance in the monitoring of polycythemia

Journal of Molecular Diagnostics

Volumn 13, Issue 3, 2011, Pages 263-270

  Carillo, Serge ^a,b   Henry, Laurent ^a,b   Lippert, Eric ^c   Girodon, François ^d   Guiraud, Isabelle ^a,b   Richard, Céline ^e   Dubois Galopin, Frédérique ^e   Cleyrat, Cedric ^f   Jourdan, Eric ^g   Kralovics, Robert ^g   Hermouet, Sylvie ^f   Lavabre Bertrand, Thierry ^a,b  

^a DEPARTMENT OF NEUROLOGY   (France)

^b UNIVERSITÉ DE MONTPELLIER   (France)

^c BORDEAUX UNIVERSITY HOSPITAL   (France)

^d DIJON UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^f NANTES UNIVERSITY HOSPITAL   (France)

^g ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; ERYTHROPOIETIN; JANUS KINASE 2;

ADULT; AGED; ALLELE; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST ACCURACY STUDY; ERYTHROCYTOSIS; EXON; FEMALE; GENE SEQUENCE; HIGH RESOLUTION MELTING; HUMAN; MALE; MELTING POINT; MOLECULAR CLONING; MOLECULAR DIAGNOSIS; MUTANT; MUTATION; NUCLEOTIDE SEQUENCE; OPTICAL RESOLUTION; POLYCYTHEMIA; POLYCYTHEMIA VERA; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY;

EID: 79954579303     PISSN: 15251578     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jmoldx.2010.12.002     Document Type: Article

References (21)

1. Baxter EJ, Scott LM, Campbell PJ, East C, Fourouclas N, Swanton S, Vassiliou GS, Bench AJ, Boyd EM, Curtin N, Scott MA, Erber WN, Green AR; Cancer Genome Project: Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005, 365:1054-1061 (Pubitemid 40386783)
2. James C, Ugo V, Le Couedic JP, Staerk J, Delhommeau F, Lacout C, Garçon L, Raslova H, Berger R, Bennaceur-Griscelli A, Villeval JL, Constantinescu SN, Casadevall N, Vainchenker W: A unique clonal JAK2 mutation leading to constitutive signalling causes polycythemia vera. Nature 2005, 434:1144-1148 (Pubitemid 40663494)
3. Kralovics R, Passamonti F, Buser AS, Teo SS, Tiedt R, Passweq JR, Tichelli A, Cazzola M, Skoda RC: A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005, 352:1779-1790 (Pubitemid 40570926)
4. Levine RL, Wadleigh M, Cools J, Ebert BL, Wernig G, Huntly BJ, Boggon TJ, Wlodarska I, Clark JJ, Moore S, Adelsperger J, Koo S, Lee JC, Gabriel S, Mercher T, D'Andrea A, Fröhling S, Döhner K, Marynen P, Vandenberghe P, Mesa RA, Tefferi A, Griffin JD, Eck MJ, Sellers WR, Meyerson M, Golub TR, Lee SJ, Gilliland DG: Activating mutations in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia and myeloid metaplasia with myelofibrosis. Cancer Cell 2005, 7:387-397 (Pubitemid 40544655)
5. Butcher CM, Hahn U, To LB, Gecz J, Wilkins EJ, Scott HS, Bardy PG, D'Andrea RJ: Two novel JAK2 exon 12 mutations in JAK2V617Fnegative polycythaemia vera patients. Leukemia 2008, 22:870-873 (Pubitemid 351552644)
6. Martínez-Avilés L, Besses C, Alvarez-Larrán A, Cervantes F, Hernández-Boluda JC, Bellosillo B: JAK2 exon 12 mutations in polycythemia vera or idiopathic erythrocytosis. Haematologica 2007, 92:1717-1718 (Pubitemid 350248259)
7. Pardanani A, Lasho TL, Finke C, Hanson CA, Tefferi A: Prevalence and clinicopathologic correlates of JAK2 exon 12 mutations in JAK2V617F-negative polycythemia vera. Leukemia 2007, 21:1960-1963 (Pubitemid 47299970)
8. Percy MJ, Scott LM, Erber WN, Harrison CN, Reilly JT, Jones FG, Green AR, McMullin MF: The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels. Haematologica 2007, 92:1607-1614 (Pubitemid 350248239)
9. Pietra D, Li S, Brisci A, Passamonti F, Rumi E, Theocharides A, Ferrari M, Gisslinger H, Kralovics R, Cremonesi L, Skoda R, Cazzola M: Somatic mutations of JAK2 exon 12 in patients with JAK2 (V617F)-negative myeloproliferative disorders. Blood 2008, 111: 1686-1689 (Pubitemid 351213460)
10. Scott LM, Tong W, Levine RL, Scott MA, Beer PA, Stratton MR, Futreal PA, Erber WN, McMullin MF, Harrison CN, Warren AJ, Gilliland DG, Lodish HF, Green AR: JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis. N Engl J Med 2007, 356:459-468 (Pubitemid 46193073)
11. Bernardi M, Ruggeri M, Albiero E, Madeo D, Rodeghiero F: Isolated erythrocytosis in V617F negative patients with JAK2 exon 12 mutations: report of a new mutation. Am J Hematol 2009, 84:258-260
12. Li S, Kralovics R, De Libero G, Theocharides A, Gisslinger H, Skoda RC: Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations. Blood 2008, 111:3863-3866
13. Scott LM, Beer PA, Bench AJ, Erber WN, Green AR: Prevalance of JAK2 V617F and exon 12 mutations in polycythaemia vera. Br J Haematol 2007, 139:511-512 (Pubitemid 47512179)
14. Cazzola M: Somatic mutations of JAK2 exon12 as a molecular basis of erythrocytosis. Haematologica 2007, 92:1585-1589 (Pubitemid 350248235)
15. Jones AV, Cross NC, White HE, Green AR, Scott LM: Rapid identification of JAK2 exon12 mutations using high resolution melting analysis. Haematologica 2008, 93:1560-1564
16. Rapado I, Grande S, Albizua E, Ayala R, Hernández JA, Gallardo M, Gilsanz F, Martinez-Lopez J: High resolution melting analysis for JAK2 Exon 14 and Exon 12 mutations: a diagnostic tool for myeloproliferative neoplasms. J Mol Diagn 2009, 11:155-161
17. Ugo V, Tondeur S, Menot ML, Bonnin N, Le Gac G, Tonetti C, Mansat-De Mas V, Lecucq L, Kiladjian JJ, Chomienne C, Dosquet C, Parquet N, Darnige L, Porneuf M, Escoffre-Barbe M, Giraudier S, Delabesse E, Cassinat B; French Intergroup of Myeloproliferative disorders: Interlaboratory development and validation of a HRM method applied to the detection of JAK2 exon 12 mutations in polycythemia vera patients. PLoS One 5:e8893
18. Schnittger S, Bacher U, Haferlach C, Geer T, Müller P, Mittermüller J, Petrides P, Schlag R, Sandner R, Selbach J, Slawik HR, Tessen HW, Wehmeyer J, Kern W, Haferlach T: Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera. Haematologica 2009, 94:414-418
19. Thiele J, Kvasnycka HM, Orazi A, Tefferi A, Birgegard G: Polycythemia vera. WHO classification of tumours of haematopoietic and lymphoid tissues, ed 4. Edited by Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri ES, Stein H, Thiele J, Vardiman JW. Geneva: World Health Organisation; IARC Press, 2008, pp 40-43
20. Lippert E, Boissinot M, Kralovics R, Girodon F, Dobo I, Praloran V, Boiret-Dupré N, Skoda RC, Hermouet S: The JAK2-V617F mutation is frequently present at diagnosis in patients with essential thrombocythemia and polycythemia vera. Blood 2006, 108:1865-1867 (Pubitemid 44394995)
21. Palais RA, Liew MA, Wittwer CT: Quantitative heteroduplex analysis for single nucleotide polymorphism genotyping. Anal Biochem 2005, 346:167-175 (Pubitemid 41456639)